222 related articles for article (PubMed ID: 23168009)
21. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
Wijeysundera DN; Duncan D; Nkonde-Price C; Virani SS; Washam JB; Fleischmann KE; Fleisher LA
J Am Coll Cardiol; 2014 Dec; 64(22):2406-25. PubMed ID: 25091545
[TBL] [Abstract][Full Text] [Related]
22. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.
Bosch X; Marrugat J; Sanchis J
Cochrane Database Syst Rev; 2013 Oct; (10):CD002130. PubMed ID: 24136036
[TBL] [Abstract][Full Text] [Related]
23. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
[TBL] [Abstract][Full Text] [Related]
24. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event.
Perez MI; Musini VM; Wright JM
Cochrane Database Syst Rev; 2009 Oct; (4):CD006743. PubMed ID: 19821384
[TBL] [Abstract][Full Text] [Related]
25. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
26. The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study.
Nicolau JC; Furtado RHM; Baracioli LM; Lara LM; Dalçóquio TF; Scanavini Junior MA; Pereira CAC; Lima VM; Gonçalves TM; Colodetti R; Ferrari AG; Lopes RD; Giugliano RP
Cardiovasc Drugs Ther; 2018 Oct; 32(5):435-442. PubMed ID: 30128818
[TBL] [Abstract][Full Text] [Related]
27. Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study.
Mohammad MA; Andell P; Koul S; Desta L; Jernberg T; Omerovic E; Spaak J; Fröbert O; Jensen J; Engstrøm T; Hofman-Bang C; Persson H; Erlinge D
EuroIntervention; 2017 Jun; 13(2):e210-e218. PubMed ID: 28242589
[TBL] [Abstract][Full Text] [Related]
28. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of randomized controlled trials of intracoronary versus intravenous administration of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention for acute coronary syndrome.
Friedland S; Eisenberg MJ; Shimony A
Am J Cardiol; 2011 Nov; 108(9):1244-51. PubMed ID: 22000626
[TBL] [Abstract][Full Text] [Related]
30. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
Misumida N; Harjai K; Kernis S; Kanei Y
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
[TBL] [Abstract][Full Text] [Related]
31. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
[TBL] [Abstract][Full Text] [Related]
32. The effect of different treatment durations of clopidogrel in patients with non-ST-segment elevation acute coronary syndromes: a systematic review and value of information analysis.
Rogowski W; Burch J; Palmer S; Craigs C; Golder S; Woolacott N
Health Technol Assess; 2009 Jun; 13(31):iii-iv, ix-xi, 1-77. PubMed ID: 19573471
[TBL] [Abstract][Full Text] [Related]
33. Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.
Kuyper LM; Khan NA
Can J Cardiol; 2014 May; 30(5 Suppl):S47-53. PubMed ID: 24750981
[TBL] [Abstract][Full Text] [Related]
34. First-line drugs for hypertension.
Wright JM; Musini VM
Cochrane Database Syst Rev; 2009 Jul; (3):CD001841. PubMed ID: 19588327
[TBL] [Abstract][Full Text] [Related]
35. β-blocker dosage and outcomes after acute coronary syndrome.
Allen JE; Knight S; McCubrey RO; Bair T; Muhlestein JB; Goldberger JJ; Anderson JL
Am Heart J; 2017 Feb; 184():26-36. PubMed ID: 27892884
[TBL] [Abstract][Full Text] [Related]
36. Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials.
Verdoia M; Schaffer A; Barbieri L; Cassetti E; Piccolo R; Galasso G; Marino P; Sinigaglia F; De Luca G
J Cardiovasc Pharmacol; 2014 Apr; 63(4):339-50. PubMed ID: 24336016
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
Hong J; Barry AR
Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
[TBL] [Abstract][Full Text] [Related]
38. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
[TBL] [Abstract][Full Text] [Related]
39. A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
de Peuter OR; Lussana F; Peters RJ; Büller HR; Kamphuisen PW
Neth J Med; 2009 Oct; 67(9):284-94. PubMed ID: 19841485
[TBL] [Abstract][Full Text] [Related]
40. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.
Bosch X; Marrugat J; Sanchis J
Cochrane Database Syst Rev; 2010 Sep; (9):CD002130. PubMed ID: 20824831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
